Cargando…

Assessment of glucose homeostasis in young adult female β-thalassemia major patients (β-TM) with acquired hypogonadotropic hypogonadism (AHH) never treated with sex steroids compared to eugonadal β-TM patients with spontaneous menstrual cycles

BACKGROUND: Acquired ypogonadotropic hypogonadism (AHH) is the most prevalent endocrine complication in thalassemia major (TM). STUDY DESIGN: Considering the detrimental effect of estrogen deficiency on glucose metabolism, the ICET-A Network promoted a retrospective study on the long-term effects of...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Sanctis, Vincenzo, Daar, Shahina, Soliman, Ashraf T, Tzoulis, Ploutarchos, Di Maio, Salvatore, Kattamis, Christos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mattioli 1885 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308476/ https://www.ncbi.nlm.nih.gov/pubmed/37326269 http://dx.doi.org/10.23750/abm.v94i3.14147

Ejemplares similares

Retrospective study on long-term effects of hormone replacement therapy (HRT) and iron chelation therapy on glucose homeostasis and insulin secretion in female ß- thalassemia major (β-TM) patients with acquired hypogonadotropic- hypogonadism (AHH)
por: De Sanctis, Vincenzo, et al.
Publicado: (2023)

Screening for glucose dysregulation in β-thalassemia major (β-TM): An update of current evidences and personal experience
por: De Sanctis, Vincenzo, et al.
Publicado: (2022)

The effects of excess weight on glucose homeostasis in young adult females with β-thalassemia major (β-TM): A preliminary retrospective study
por: De Sanctis, Vincenzo, et al.
Publicado: (2023)

Evolution of glucose-insulin homeostasis in children with β- thalassemia major (β -TM): A twenty-year retrospective ICET- A observational analysis from early childhood to young adulthood
por: De Sanctis, Vincenzo, et al.
Publicado: (2022)

Acquired Hypogonadotropic Hypogonadism (AHH) in Thalassaemia Major Patients: An Underdiagnosed Condition?
por: De Sanctis, Vincenzo, et al.
Publicado: (2016)

Pancreatic changes affecting glucose homeostasis in transfusion dependent β-thalassemia (TDT): a short review
por: de Sanctis, Vincenzo, et al.
Publicado: (2021)

Longitudinal study of ICET-A on glucose tolerance, insulin sensitivity and β-cell secretion in eleven β-thalassemia major patients with mild iron overload
por: De Sanctis, Vincenzo, et al.
Publicado: (2023)

A study of isolated hyperglycemia (blood glucose ≥155 mg/dL) at 1-hour of oral glucose tolerance test (OGTT) in patients with β-transfusion dependent thalassemia (β-TDT) followed for 12 years
por: de Sanctis, Vincenzo, et al.
Publicado: (2021)

Glucose Homeostasis and Assessment of β-Cell Function by 3-hour Oral Glucose Tolerance (OGTT) in Patients with β-Thalassemia Major with Serum Ferritin below 1,000 ng/dL: Results from a Single ICET-A Centre
por: de Sanctis, Vincenzo, et al.
Publicado: (2023)

Evolution of combined impaired fasting glucose and impaired glucose tolerance in β-thalassemia major: Results in 58 patients with a mean 7.7- year follow-up
por: De Sanctis, Vincenzo, et al.
Publicado: (2022)

Long-Term Follow-up of β-Transfusion-Dependent Thalassemia (TDT) Normoglycemic Patients with Reduced Insulin Secretion to Oral Glucose Tolerance Test (OGTT): A Pilot Study
por: de Sanctis, Vincenzo, et al.
Publicado: (2021)

Insulin-like growth factor -1 (IGF-1) and glucose dysregulation in young adult patients with β-thalassemia major: causality or potential link?
por: De Sanctis, Vincenzo, et al.
Publicado: (2022)

Glucose Metabolism and Insulin Response to Oral Glucose Tolerance Test (OGTT) in Prepubertal Patients with Transfusion-Dependent β-thalassemia (TDT): A Long-Term Retrospective Analysis
por: De Sanctis, Vincenzo, et al.
Publicado: (2021)

Clinical characteristics, biochemical parameters and insulin response to oral glucose tolerance test (OGTT) in 25 transfusion dependent β-thalassemia (TDT) patients recently diagnosed with diabetes mellitus (DM)
por: de Sanctis, Vincenzo, et al.
Publicado: (2021)

Hypomenorrhea in Adolescents and Youths: Normal Variant or Menstrual Disorder ? Revision of Literature and Personal Experience
por: de Sanctis, Vincenzo, et al.
Publicado: (2022)

Hypogonadism in male thalassemia major patients: pathophysiology, diagnosis and treatment
por: De Sanctis, Vincenzo, et al.
Publicado: (2018)

The use of oral glucose-lowering agents (GLAs) in β-thalassemia patients with diabetes: Preliminary data from a retrospective study of ICET-A Network
por: de Sanctis, Vincenzo, et al.
Publicado: (2022)

Prevalence of glucose dysregulation (GD) in patients with β-thalassemias in different countries: A preliminary ICET-A survey
por: de Sanctis, Vincenzo, et al.
Publicado: (2021)

Retrospective observational studies: Lights and shadows for medical writers
por: de Sanctis, Vincenzo, et al.
Publicado: (2022)

A Multicenter ICET-A Study on Age at Menarche and Menstrual Cycles in Patients with Transfusion-Dependent Thalassemia (TDT) who Started Early Chelation Therapy with Different Chelating Agents
por: Di Maio, Salvatore, et al.
Publicado: (2023)

Oral glucose tolerance test: how to maximize its diagnostic value in children and adolescents
por: De Sanctis, Vincenzo, et al.
Publicado: (2022)

Unilateral breast enlargement in males during adolescence (10-19 years): review of current literature and personal experience
por: De Sanctis, Vincenzo, et al.
Publicado: (2023)

Recent advancements in glucose dysregulation and pharmacological management of osteoporosis in transfusion-dependent thalassemia (TDT): an update of ICET-A (International Network of Clinicians for Endocrinopathies in Thalassemia and Adolescence Medicine)
por: Tzoulis, Ploutarchos, et al.
Publicado: (2023)

The experience of a tertiary unit on the clinical phenotype and management of hypogonadism in female adolescents and young adults with transfusion dependent thalassemia
por: Vincenzo, De Sanctis, et al.
Publicado: (2019)

Thyroid Disorders in Homozygous β-Thalassemia: Current Knowledge, Emerging Issues and Open Problems
por: De Sanctis, Vincenzo, et al.
Publicado: (2019)

Approach to the management of β thalassemia major associated osteoporosis - a long-standing relationship revisited
por: Yavropoulou, Maria P., et al.
Publicado: (2022)

β-Thalassemia Distribution in the Old World: an Ancient Disease Seen from a Historical Standpoint
por: De Sanctis, Vincenzo, et al.
Publicado: (2017)

KLB, encoding β‐Klotho, is mutated in patients with congenital hypogonadotropic hypogonadism
por: Xu, Cheng, et al.
Publicado: (2017)

Clinical and Biochemical Data of Adult Thalassemia Major patients (TM) with Multiple Endocrine Complications (MEC) versus TM Patients with Normal Endocrine Functions: A long-term Retrospective Study (40 years) in a Tertiary Care Center in Italy
por: De Sanctis, Vincenzo, et al.
Publicado: (2016)

Does Testosterone Replacement Therapy Promote an Augmented Risk of Thrombotic Events in Thalassemia Major Male Patients with Hypogonadism?
por: De Sanctis, Vincenzo, et al.
Publicado: (2017)

Hematological and biochemical evaluation of β-thalassemia major (βTM) patients in Gaza Strip: A cross-sectional study
por: Ayyash, Hani, et al.
Publicado: (2018)

An ICET-A survey on occult and emerging endocrine complications in patients with β-thalassemia major: Conclusions and recommendations
por: Vincenzo, De Sanctis, et al.
Publicado: (2018)

Serum concentrations of dihydrotestosterone are associated with symptoms of hypogonadism in biochemically eugonadal men
por: Sansone, A., et al.
Publicado: (2021)

Final adult height and endocrine complications in young adults with β-thalassemia major (TM) who received oral iron chelation (OIC) in comparison with those who did not use OIC
por: Soliman, Ashraf T, et al.
Publicado: (2018)

Hypogonadotropic Hypogonadism Revisited
por: Fraietta, Renato, et al.
Publicado: (2013)

Genetics of hypogonadotropic hypogonadism
por: Millar, Adam C., et al.
Publicado: (2021)

PredβTM: A Novel β-Transmembrane Region Prediction Algorithm
por: Roy Choudhury, Amrita, et al.
Publicado: (2015)

Deferasirox (Exjade®) significantly improves cardiac T2* in heavily iron-overloaded patients with β-thalassemia major
por: Pathare, Anil, et al.
Publicado: (2009)

The Genetic Backdrop of Hypogonadotropic Hypogonadism
por: Szeliga, Anna, et al.
Publicado: (2021)

Changing patterns in the epidemiology of β‐thalassemia
por: Kattamis, Antonis, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gnngghta434ug7bj9f2viv4gh7